Rock Edwin 4
4 · GLYCOMIMETICS INC · Filed Sep 25, 2023
Insider Transaction Report
Form 4
Rock Edwin
Chief Medical Officer
Transactions
- Purchase
Common Stock
2023-09-21$1.38/sh+35,000$48,300→ 345,000 total - Purchase
Common Stock
2023-09-22$1.38/sh+30,403$41,956→ 375,403 total
Footnotes (2)
- [F1]The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.35 to $1.40 per share, with a weighted average purchase price of $1.38 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.37 to $1.40 per share, with a weighted average purchase price of $1.38 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.